ALOCRIL Trademark

Trademark Overview

On Friday, September 17, 1999, a trademark application was filed for ALOCRIL with the United States Patent and Trademark Office. The USPTO has given the ALOCRIL trademark a serial number of 75802644. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 29, 2021. This trademark is owned by ALLERGAN, INC.. The ALOCRIL trademark is filed in the Pharmaceutical Products category with the following description:

OPHTHALMIC PHARMACEUTICALS FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
alocril

General Information

Serial Number75802644
Word MarkALOCRIL
Filing DateFriday, September 17, 1999
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 29, 2021
Registration Number2458487
Registration DateTuesday, June 5, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 9, 2000

Trademark Statements

Goods and ServicesOPHTHALMIC PHARMACEUTICALS FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITIS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 13, 1999
Primary Code005
First Use Anywhere DateThursday, August 26, 1999
First Use In Commerce DateFriday, February 4, 2000

Trademark Owner History

Party NameALLERGAN, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameALLERGAN, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameALLERGAN, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Saturday, May 29, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, May 29, 2021REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, May 29, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 29, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 23, 2021TEAS SECTION 8 & 9 RECEIVED
Friday, June 5, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, August 22, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, August 22, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, August 19, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 10, 2010TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 18, 2006CASE FILE IN TICRS
Wednesday, August 30, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 12, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, June 12, 2006TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 5, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, January 30, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 29, 2001ASSIGNED TO EXAMINER
Thursday, January 4, 2001STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 24, 2000USE AMENDMENT FILED
Tuesday, August 1, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2000PUBLISHED FOR OPPOSITION
Saturday, April 8, 2000NOTICE OF PUBLICATION
Thursday, January 13, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 13, 2000ASSIGNED TO EXAMINER

Related Keywords

alocril conjunctivitis allergic treatment pharmaceuticals ophthalmic